Interpreting the Regulatory Perspective on Adaptive Designs
In 2010, the FDA published draft guidance on how to conduct an adaptive design clinical trial. In 2016, final guidance was published on a similar topic, while also emphasizing the FDA's support for using adaptive designs for clinical trials.
Download the article by Veristat's top statistical experts to understand the advantages of adaptive designs and how they can help increase the chances of the success of a clinical trial.
downloadExplore Our Key Related Services
Please fill out this form to access your resource.